Postmenopausal hormone treatment

JAMA

Volumn 301, Issue 23, 2009, Pages 2493-2495

  Hulley, Stephen ^a   Grady, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE;

CANCER RISK; COGNITIVE DEFECT; DEMENTIA; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MENOPAUSAL SYNDROME; MENOPAUSE RELATED DISORDER; NONHUMAN; NOTE; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; STROKE; TREATMENT OUTCOME; UTERUS CANCER; VENOUS THROMBOEMBOLISM; CORONARY ARTERY DISEASE; FEMALE; HISTORY; RANDOMIZED CONTROLLED TRIAL;

CORONARY ARTERY DISEASE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; POSTMENOPAUSE; PROGESTINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67649239362     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.847     Document Type: Note

References (15)

1. Hulley S, Grady D, Bush T, et al; Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280(7):605-613.
2. Wilson RA. Feminine Forever. Philadelphia, PA: Lippincott; 1966.
3. Grady D, Cummings SR, Petitti DB, Rubin SM, Audet A; American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med. 1992;117(12):1038-1041.
4. Grady D, Herrington D, Bittner V, et al; HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study Follow-up (HERS II). JAMA. 2002;288(1):49-57.
5. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
6. Shumaker SA, Legault C, Rapp SR, et al; WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651-2662.
7. Anderson GL, Limacher M, Assaf AR, et al; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
8. Shumaker SA, Legault C, Kuller L, et al; Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA. 2004;291(24):2947- 2958.
9. Hulley SB, Grady D. The WHI estrogen-alone trial: do things look any better? JAMA. 2004;291(14):1769-1771.
10. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk for cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465-1477.
11. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1):47-53.
12. Scarabin PY, Oger E, Plu-Bureau G; EStrogen and THromboEmbolism Risk Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003;362(9382):428-432.
13. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. 2001;75(6):1065-1079.
14. Ettinger B, Ensrud K, Wallace R, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004;104(3):443-451.
15. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Research. http://breast-cancer-research.com/content/9/3/R28. Posted May 3, 2007. Accessed May 22, 2009.